α-Synucleinopathies are a group of neurodegenerative disorders char- acterized by the presence of intracytoplasmic Lewy bodies in Parkinson’s dis- ease and dementia with Lewy bodies as well as glial cytoplasmic inclusions in multiple system atrophy. The main component of these inclusions is aggregated α-synuclein which supports a strong link between α-synuclein and disease patho- genesis. The mechanisms responsible for α-synuclein aggregation and subsequent degeneration are largely unknown. However, several factors have been shown to accelerate the aggregation of α-synuclein in vitro and suggested to contribute to the pathogenesis of α-synucleinopathies. Several different proteins can stimulate the aggregation process in vitro and have been shown to colocalize with aggre- gated α-synuclein in pathological brain tissue. We review our current knowledge on proteins with a putative involvement in α-synuclein-dependent degeneration based on aggregatory properties, colocalization with aggregated α-synuclein, or genetic evidence.
CITATION STYLE
Kragh, C. L., & Jensen, P. H. (2008). Novel Proteins in α-Synucleinopathies. In Protein Folding and Misfolding: Neurodegenerative Diseases (pp. 207–224). Springer Netherlands. https://doi.org/10.1007/978-1-4020-9434-7_9
Mendeley helps you to discover research relevant for your work.